Cochlear Aktie

159,72EUR -23,10EUR -12,64%
Cochlear für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN: 898321 / ISIN: AU000000COH5
<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Personal

2020 2021 2022 2023 2024
Personal am Ende des Jahres 4 000 4 000 4 500 4 800 5 000
Umsatz pro Mitarbeiter in Mio. EUR 0,34 0,37 0,36 0,41 0,45

Bilanz (in Mio. AUD) - Aktiva

2020 2021 2022 2023 2024
Summe Umlaufvermögen 1 478 1 230 1 327 1 362 1 452
Summe Anlagevermögen 1 106 1 208 1 138 1 207 1 293
Summe Aktiva 2 583 2 438 2 465 2 569 2 745

Bilanz (in Mio. AUD) - Passiva

2020 2021 2022 2023 2024
Summe Fremdkapital 1 182 737 779 820 905
Summe Eigenkapital 1 402 1 702 1 686 1 749 1 841
Summe Passiva 2 583 2 438 2 465 2 569 2 745

Adresse

1 University Avenue, 2109 Sydney
Telefon +61 (2) 9428-6555
Fax +61 (2) 9428-6353
Internet http://www.cochlear.com/

Management

Brian Kaplan
Senior VP-Global Clinical Strategy & Innovation
Bruce G. Robinson
Independent Non-Executive Director
Caroline Clarke
Non-Executive Director
Catriona Alison Deans
Chairman
Christine Frances McLoughlin
Independent Non-Executive Director
Dean Phizacklea
Senior Vice President-Global Marketing
Diggory William Howitt
President, CEO, Executive Director & MD
Glen Francis Boreham
Independent Non-Executive Director
Jan Janssen
Chief Technology Officer
Jennifer Hornery
Senior Vice President-People & Culture
Karen Lee Collett Penrose
Independent Non-Executive Director
Karen O’Driscoll
Chief Information Officer
Kristina Devon
Vice President-Investor Relations & Sustainability
Kristy Jo
Co-Secretary
Lisa Aubert
President-North America
Michael Grenfell Daniell
Independent Non-Executive Director
Michael del Prado
Independent Non-Executive Director
Rob McGrory
Co-Secretary
Sarah Thom
Chief Financial Officer
Stuart Sayers
President-Asia Pacific & Latin America